Vista Gen Therapeutics Inc is categorized under Biological Research in South San Francisco, CA and active since 2011.
Vista Gen Therapeutics Inc was established in 2011, and today employs 1 to 4, earning Unknown per year. This is a Biological Research business, which does work in the B2B market, and is classified as a Biological Research, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact Shawn Singh, Chief Executive Officer at the company’s headquarters by writing to 343 Allerton Avenue, South San Francisco, California CA 94080 or by phoning (650) 244-9990. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Vista Gen Therapeutics Inc |
Contact Person: | Shawn Singh, Chief Executive Officer |
Address: | 343 Allerton Avenue, South San Francisco, California 94080 |
Phone Number: | (650) 244-9990 |
Website Address: | vistagen.com |
Annual Revenue (USD): | Unknown |
Founded: | 2011 |
Location Type: | Headquarters |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Biological Research |
SIC Code: | 8731 |
NAICS Code: | 5417114 |
Share This Business: |
Vista Gen Therapeutics Inc was started in 2011 to provide professional Biological Research under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Shawn Singh, Chief Executive Officer for inquiries that concern Vista Gen Therapeutics Inc by calling the company number (650) 244-9990, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Vista Gen Therapeutics Inc can be found at the coordinates 37.65327,-122.39127 as well as the street address 343 Allerton Avenue in South San Francisco, California 94080.
For its online presence, you may visit Vista Gen Therapeutics Inc’s website at vistagen.com and engage with its social media outlets through on Twitter and on Facebook.